{"answer":{"query":"Promacta","resolved_as":"applications","packages":7,"applications":["NDA022291","NDA207027"],"identity":{"application_numbers":["NDA022291","NDA207027"],"marketing_categories":["NDA"],"labelers":[],"dosage_forms":[{"text":"TABLET, FILM COATED","untrusted":true},{"text":"POWDER, FOR SUSPENSION","untrusted":true}],"marketing_start":{"earliest":"2016-04-01","latest":"2020-03-27","packages_with_a_start_date":7}},"generic_entry":[{"application":"NDA022291","date":"2026-01-13","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"7547719*PED","productNo":"005"},"latest_patent_expiry":"2026-01-13","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":10,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":1,"exclusivities_listed":0,"fact_id":"4a1dbd0521bf14a494500509"},{"application":"NDA207027","date":"2026-01-13","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"7547719*PED","productNo":"001"},"latest_patent_expiry":"2026-01-13","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":4,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":1,"exclusivities_listed":0,"fact_id":"dc2df717f94c77c2d317fe0e"}],"label_history":{"events_total":38,"non_cmc_events":34,"counts_by_class":{"LABELING":27,"EFFICACY":5,"REMS":2},"cmc_events":4,"recent_non_cmc_events":[{"application":"NDA022291","submission_no":41,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-06-06","documents":[{"type":"Label","date":"2025-06-09","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022291s041,207027s020lbl.pdf","untrusted":true}},{"type":"Letter","date":"2025-06-09","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/022291Orig1s041,207027Orig1s020ltr.pdf","untrusted":true}}],"fact_id":"bb68f440f6ebb38a2bb61416"},{"application":"NDA207027","submission_no":20,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-06-06","documents":[{"type":"Label","date":"2025-06-09","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022291s041,207027s020lbl.pdf","untrusted":true}},{"type":"Letter","date":"2025-06-09","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/022291Orig1s041,207027Orig1s020ltr.pdf","untrusted":true}}],"fact_id":"b160c1b57948d8d5ed960dd1"},{"application":"NDA022291","submission_no":37,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2023-03-09","documents":[{"type":"Letter","date":"2023-03-10","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022291Orig1s037;207027Orig1s017ltr.pdf","untrusted":true}},{"type":"Label","date":"2023-03-10","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf","untrusted":true}}],"fact_id":"3166e2e95f6af4998181c1fc"},{"application":"NDA207027","submission_no":17,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2023-03-09","documents":[{"type":"Letter","date":"2023-03-10","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022291Orig1s037;207027Orig1s017ltr.pdf","untrusted":true}},{"type":"Label","date":"2023-03-10","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf","untrusted":true}}],"fact_id":"a4603ec11fb13369937b1e7f"},{"application":"NDA022291","submission_no":33,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2022-03-31","documents":[{"type":"Letter","date":"2022-04-04","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/022291Orig1s033; 207027Orig1s015ltr.pdf","untrusted":true}},{"type":"Label","date":"2022-04-05","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022291s033,207027s015lbl.pdf","untrusted":true}}],"fact_id":"9d3b3fc057a84acf383eac2b"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":7,"te_code_counts":{"AB":6,"NOT_PROVIDED":1},"marketing_status_counts":{"Prescription":6,"Discontinued":1},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA022291","product_no":"004","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"PROMACTA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 12.5MG ACID","untrusted":true}},{"application":"NDA022291","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"PROMACTA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 25MG ACID","untrusted":true}},{"application":"NDA022291","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"PROMACTA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 50MG ACID","untrusted":true}},{"application":"NDA022291","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"PROMACTA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 75MG ACID","untrusted":true}},{"application":"NDA022291","product_no":"005","te_code":null,"marketing_status":"Discontinued","drug_name":{"text":"PROMACTA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","untrusted":true}},{"application":"NDA207027","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"PROMACTA KIT","untrusted":true},"form":{"text":"FOR SUSPENSION;ORAL","untrusted":true},"strength":{"text":"EQ 12.5MG ACID/PACKET","untrusted":true}},{"application":"NDA207027","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"PROMACTA KIT","untrusted":true},"form":{"text":"FOR SUSPENSION;ORAL","untrusted":true},"strength":{"text":"EQ 25MG ACID/PACKET","untrusted":true}}]},"recalls":{"recalls_total":2,"counts_by_class":{"Class I":1,"Class II":1},"packages_of_these_applications":7,"most_recent":[{"recall_number":"D-1309-2019","classification":"Class I","status":"Terminated","report_date":"2019-05-29","recall_initiated":"2019-05-11","recalling_firm":{"text":"Novartis Pharmaceuticals Corp.","untrusted":true},"reason":{"text":"Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.","untrusted":true},"packages_named":7,"fact_id":"f2b2dcd9fe315d34004adb32"},{"recall_number":"D-0770-2018","classification":"Class II","status":"Terminated","report_date":"2018-05-16","recall_initiated":"2018-04-03","recalling_firm":{"text":"Kroger Specialty Pharmacy, Inc.","untrusted":true},"reason":{"text":"Lack of Processing Controls.","untrusted":true},"packages_named":1,"fact_id":"328628dcbc49c41eaafa8ab1"}],"meaning":"FDA classifies the health hazard of a recall, not its effect on supply"},"spending":{"reported_under":{"generic":{"text":"Eltrombopag Olamine","untrusted":true},"brand":{"text":"Promacta","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":341789027.32,"claims":31379,"beneficiaries":4616,"average_spending_per_claim_usd":10892.28552,"fact_id":"5947f09c19a44a93039ba21c"},{"year":2021,"gross_spending_usd":389486269.41,"claims":32978,"beneficiaries":4960,"average_spending_per_claim_usd":11810.487883,"fact_id":"1ec303b7dcee3b6993311c8e"},{"year":2022,"gross_spending_usd":454825188.17,"claims":35692,"beneficiaries":5150,"average_spending_per_claim_usd":12743.056936,"fact_id":"810baad29ea614a4278f3cd4"},{"year":2023,"gross_spending_usd":557676106.25,"claims":39505,"beneficiaries":5708,"average_spending_per_claim_usd":14116.595526,"fact_id":"1a91558fb7c76aa0faed81fe"},{"year":2024,"gross_spending_usd":672379160.6,"claims":45852,"beneficiaries":6666,"average_spending_per_claim_usd":14664.118481,"fact_id":"3b80506f80f41a2ab6a20d96"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"rems":{"programs":[{"application":"NDA022291","program":{"text":"Promacta","untrusted":true},"rems_id":"44","in_force":false,"released":true,"moved_to_shared_system":false,"has_etasu":false,"program_date":"2008-11-20","last_modified":"2014-07-16","source_page":"https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=44","other_programs":0,"read_on":"2026-11-07T20:05:28.959Z","fact_id":"4e84e41ff4585edd37678c68"}],"reading":"what the FDA REMS@FDA files tie to the application on the read date; it does not say which prescribers or pharmacies take part or whether a patient needs the program"},"medicaid_state_utilization":{"year":2025,"states_with_data":1,"all_states_medicaid_reimbursed_usd":874869.29,"all_states_medicaid_paid_prescriptions":109,"top_states":[{"state":"NY","medicaid_paid_prescriptions":109,"medicaid_reimbursed_usd":874869.29,"total_reimbursed_usd":874869.29,"packages":1,"covers":"all_record_types","fact_id":"ec488209ec71435ea9d1ca9f"}],"unlabelled_state_code_xx":null,"built_from_facts":1,"facts_fee_for_service_only":0,"older_year_facts_not_used":78,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"ffb921eefd470403909377c8","field":"ndc.listing","entity":"ndc:00078068415"},{"fact_id":"5d432d9105dc959b185911fc","field":"ndc.listing","entity":"ndc:00078068515"},{"fact_id":"3d49a5a4b5ddeac38342c2a4","field":"ndc.listing","entity":"ndc:00078068615"},{"fact_id":"4a1dbd0521bf14a494500509","field":"drug.generic_entry_earliest","entity":"application:NDA022291"},{"fact_id":"89df37c122e98efe1cc1d1e9","field":"drug.patent","entity":"application:NDA022291"},{"fact_id":"dc2df717f94c77c2d317fe0e","field":"drug.generic_entry_earliest","entity":"application:NDA207027"},{"fact_id":"d0ee623b691ae9eb35cb1840","field":"drug.patent","entity":"application:NDA207027"},{"fact_id":"bb68f440f6ebb38a2bb61416","field":"drug.label_event","entity":"application:NDA022291"},{"fact_id":"b160c1b57948d8d5ed960dd1","field":"drug.label_event","entity":"application:NDA207027"},{"fact_id":"3166e2e95f6af4998181c1fc","field":"drug.label_event","entity":"application:NDA022291"},{"fact_id":"a4603ec11fb13369937b1e7f","field":"drug.label_event","entity":"application:NDA207027"},{"fact_id":"9d3b3fc057a84acf383eac2b","field":"drug.label_event","entity":"application:NDA022291"},{"fact_id":"d6f628b2b853db22f8051163","field":"drug.te_code","entity":"application:NDA022291"},{"fact_id":"afafce93705d6f80936bad79","field":"drug.marketing_status","entity":"application:NDA022291"},{"fact_id":"d3bb90c9d79bf194ad813c09","field":"drug.te_code","entity":"application:NDA022291"},{"fact_id":"56622806867fd5d29d1c99eb","field":"drug.marketing_status","entity":"application:NDA022291"},{"fact_id":"a52c3ee853047109e4dec44b","field":"drug.te_code","entity":"application:NDA022291"},{"fact_id":"ed2100590bb0c01f45553d15","field":"drug.marketing_status","entity":"application:NDA022291"},{"fact_id":"8e668ef0b231eaf7d3caccfa","field":"drug.te_code","entity":"application:NDA022291"},{"fact_id":"7d5bbaff83aa546bbd2abf03","field":"drug.marketing_status","entity":"application:NDA022291"},{"fact_id":"abc4306f5539bef696d41198","field":"drug.marketing_status","entity":"application:NDA022291"},{"fact_id":"d8ca0bfe54482bb89fb0797c","field":"drug.te_code","entity":"application:NDA207027"},{"fact_id":"dee54862eb13b19f519139f8","field":"drug.marketing_status","entity":"application:NDA207027"},{"fact_id":"2e568e43b814dc1e7d2c23b2","field":"drug.te_code","entity":"application:NDA207027"},{"fact_id":"641c992786e0fb54e0395f42","field":"drug.marketing_status","entity":"application:NDA207027"},{"fact_id":"f2b2dcd9fe315d34004adb32","field":"ndc.recall","entity":"ndc:00078068415"},{"fact_id":"328628dcbc49c41eaafa8ab1","field":"ndc.recall","entity":"ndc:00078068615"},{"fact_id":"5947f09c19a44a93039ba21c","field":"drug.partd_spending","entity":"drug:eltrombopag-olamine|promacta"},{"fact_id":"1ec303b7dcee3b6993311c8e","field":"drug.partd_spending","entity":"drug:eltrombopag-olamine|promacta"},{"fact_id":"810baad29ea614a4278f3cd4","field":"drug.partd_spending","entity":"drug:eltrombopag-olamine|promacta"},{"fact_id":"1a91558fb7c76aa0faed81fe","field":"drug.partd_spending","entity":"drug:eltrombopag-olamine|promacta"},{"fact_id":"3b80506f80f41a2ab6a20d96","field":"drug.partd_spending","entity":"drug:eltrombopag-olamine|promacta"},{"fact_id":"4e84e41ff4585edd37678c68","field":"drug.rems","entity":"application:NDA022291"},{"fact_id":"ec488209ec71435ea9d1ca9f","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078068415:NY"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"price","reason":"no NADAC price, negotiated price or federal upper limit for these packages"},{"code":"NO_DATA","field":"supply","reason":"no FDA shortage row and no termination date for these packages"},{"code":"NO_DATA","field":"trials","reason":"no ClinicalTrials.gov record set for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"orphan_designation","reason":"no FDA orphan designation for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}